Related Experiment Video
Updated: Jan 23, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis
Tzewah V Leung1, Mitchell E Hughes1, Christine G Cambareri1
1Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
Chemotherapy, and now targeted therapies and immunotherapies, are widely used for the management of patients with all stages of lung cancer. Some challenges present when patients are receiving concomitant hemodialysis for various comorbid conditions. However, this should not immediately rule out a patient for treatment. Many drugs may be safely given to patients who are receiving hemodialysis with the proper dosing schedule and careful monitoring. This article will outline the current literature surrounding the use of these drugs in patients undergoing active hemodialysis while being treated for lung cancer.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Receiver Operating Characteristic Plot
Hemodialysis III: Nursing Management
Lung Capacity

